Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Daniel Pollyea

Concepts (466)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Leukemia, Myeloid, Acute
111
2024
596
25.660
 Why?
Bridged Bicyclo Compounds, Heterocyclic
37
2025
217
9.820
 Why?
Antineoplastic Combined Chemotherapy Protocols
49
2025
1560
8.130
 Why?
Sulfonamides
32
2025
497
7.900
 Why?
Azacitidine
23
2024
139
6.570
 Why?
Myelodysplastic Syndromes
28
2023
129
6.400
 Why?
Mutation
35
2024
3717
3.150
 Why?
Isocitrate Dehydrogenase
13
2022
52
3.000
 Why?
Hematologic Neoplasms
10
2023
141
2.870
 Why?
Antineoplastic Agents
24
2024
2046
2.840
 Why?
Neoplastic Stem Cells
14
2025
378
2.420
 Why?
Hematopoietic Stem Cell Transplantation
17
2024
576
2.350
 Why?
Neoplasm, Residual
7
2024
121
2.320
 Why?
Triazines
7
2021
38
1.980
 Why?
Aminopyridines
7
2021
98
1.910
 Why?
Graft vs Host Disease
9
2024
240
1.720
 Why?
Remission Induction
15
2021
274
1.540
 Why?
RNA Splicing Factors
3
2020
52
1.460
 Why?
Prognosis
27
2024
3774
1.430
 Why?
Humans
155
2025
129627
1.370
 Why?
Aged
58
2024
22061
1.300
 Why?
Aged, 80 and over
32
2024
7052
1.280
 Why?
Phosphoproteins
3
2020
335
1.260
 Why?
Cytarabine
8
2022
57
1.250
 Why?
Neoplasm Recurrence, Local
5
2020
958
1.170
 Why?
Leukemia
4
2023
229
1.140
 Why?
Treatment Outcome
33
2024
10219
1.070
 Why?
Salvage Therapy
5
2023
136
1.030
 Why?
Clonal Evolution
2
2017
40
1.000
 Why?
Cord Blood Stem Cell Transplantation
4
2024
99
0.970
 Why?
Drug Resistance, Neoplasm
9
2025
752
0.920
 Why?
Leukemia, Lymphocytic, Chronic, B-Cell
2
2022
67
0.900
 Why?
Nuclear Proteins
5
2018
660
0.900
 Why?
fms-Like Tyrosine Kinase 3
4
2017
47
0.900
 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
2023
281
0.880
 Why?
Molecular Targeted Therapy
7
2024
391
0.850
 Why?
Middle Aged
46
2024
31136
0.840
 Why?
Carrier Proteins
3
2017
745
0.830
 Why?
Transplantation Conditioning
9
2024
166
0.830
 Why?
Leukemia, Neutrophilic, Chronic
3
2019
5
0.820
 Why?
Dancing
1
2022
14
0.780
 Why?
Thrombocytopenia
2
2023
186
0.780
 Why?
Spliceosomes
2
2020
46
0.780
 Why?
Proto-Oncogene Proteins c-bcl-2
4
2018
234
0.750
 Why?
Anemia
2
2020
161
0.750
 Why?
Enzyme Inhibitors
5
2020
827
0.740
 Why?
Febrile Neutropenia
1
2020
3
0.710
 Why?
Splicing Factor U2AF
2
2023
16
0.680
 Why?
Male
55
2024
63671
0.670
 Why?
Female
60
2024
68735
0.650
 Why?
Receptors, Colony-Stimulating Factor
2
2017
6
0.650
 Why?
Serine-Arginine Splicing Factors
2
2019
22
0.650
 Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
6
2025
118
0.640
 Why?
Adult
33
2024
35600
0.610
 Why?
Phenylurea Compounds
7
2020
88
0.600
 Why?
DNA Methylation
3
2019
611
0.600
 Why?
Staurosporine
1
2017
20
0.580
 Why?
Stem Cells
3
2020
575
0.570
 Why?
Benzimidazoles
6
2020
162
0.550
 Why?
Protein Kinase Inhibitors
10
2025
887
0.530
 Why?
Gene Frequency
2
2017
502
0.520
 Why?
Recurrence
9
2023
1011
0.510
 Why?
Glycine
4
2021
165
0.500
 Why?
Monocytes
2
2018
553
0.500
 Why?
Neoplasms, Plasma Cell
1
2015
7
0.500
 Why?
Leukocytosis
1
2015
32
0.500
 Why?
High-Throughput Nucleotide Sequencing
2
2018
487
0.490
 Why?
Skin Neoplasms
1
2023
829
0.490
 Why?
Gene Expression
1
2020
1465
0.480
 Why?
Signal Transduction
9
2022
4931
0.480
 Why?
Retrospective Studies
16
2024
14522
0.470
 Why?
Precision Medicine
1
2018
387
0.460
 Why?
Epigenesis, Genetic
1
2019
617
0.460
 Why?
Computational Biology
1
2019
596
0.460
 Why?
Patient Safety
1
2018
287
0.450
 Why?
Pyridines
5
2023
478
0.450
 Why?
Maximum Tolerated Dose
5
2019
193
0.450
 Why?
Oxidative Phosphorylation
6
2024
188
0.450
 Why?
Medical Oncology
4
2023
269
0.450
 Why?
Induction Chemotherapy
3
2024
70
0.430
 Why?
Clinical Trials, Phase I as Topic
2
2024
51
0.430
 Why?
Hematopoiesis
4
2020
184
0.430
 Why?
Clinical Trials, Phase III as Topic
2
2024
93
0.430
 Why?
Neoplasm Proteins
4
2022
419
0.420
 Why?
Pyrazoles
1
2017
404
0.420
 Why?
Apoptosis
4
2018
2492
0.420
 Why?
Germ-Line Mutation
3
2022
142
0.410
 Why?
Immunity, Innate
1
2019
805
0.410
 Why?
Dose-Response Relationship, Drug
7
2021
2011
0.400
 Why?
Leukemia, Myeloid
1
2012
45
0.400
 Why?
Glutarates
1
2012
8
0.400
 Why?
DNA (Cytosine-5-)-Methyltransferases
2
2018
31
0.380
 Why?
RNA Splicing
4
2023
260
0.370
 Why?
Neutrophils
2
2023
1210
0.360
 Why?
Drug Delivery Systems
1
2014
333
0.360
 Why?
Antibodies, Monoclonal, Humanized
7
2023
757
0.360
 Why?
Follow-Up Studies
8
2020
4894
0.360
 Why?
Young Adult
15
2024
12455
0.350
 Why?
Neoplasms
4
2018
2455
0.350
 Why?
United States Food and Drug Administration
2
2022
205
0.350
 Why?
Aldehyde Dehydrogenase
3
2017
101
0.340
 Why?
Survival Rate
10
2020
1872
0.340
 Why?
Leukocyte Count
2
2024
326
0.330
 Why?
Rhipicephalus sanguineus
1
2009
1
0.330
 Why?
Triatoma
1
2009
5
0.330
 Why?
Wasps
1
2009
8
0.330
 Why?
Insect Bites and Stings
1
2009
11
0.330
 Why?
Syncope
1
2009
51
0.320
 Why?
Electron Transport Complex II
2
2019
25
0.310
 Why?
Cytokines
4
2020
2021
0.310
 Why?
Kaplan-Meier Estimate
5
2020
851
0.310
 Why?
Mutant Proteins
2
2019
100
0.300
 Why?
Risk Assessment
5
2024
3262
0.300
 Why?
Influenza A Virus, H1N1 Subtype
1
2010
146
0.300
 Why?
Administration, Oral
4
2018
787
0.300
 Why?
Cell Self Renewal
2
2019
53
0.300
 Why?
Proto-Oncogene Proteins
2
2018
636
0.300
 Why?
Acute Disease
3
2023
979
0.300
 Why?
Anaphylaxis
1
2009
98
0.300
 Why?
Randomized Controlled Trials as Topic
3
2024
1365
0.300
 Why?
Bone Marrow
4
2017
273
0.290
 Why?
Transplantation, Homologous
6
2022
402
0.290
 Why?
Immunotherapy, Adoptive
2
2022
300
0.280
 Why?
Survival Analysis
6
2020
1269
0.280
 Why?
Gene Expression Regulation, Leukemic
3
2016
50
0.280
 Why?
Drug Administration Schedule
4
2020
767
0.270
 Why?
Disease-Free Survival
5
2022
646
0.270
 Why?
Mitochondria
3
2024
876
0.260
 Why?
Thrombocythemia, Essential
2
2016
7
0.260
 Why?
Primary Myelofibrosis
2
2016
9
0.260
 Why?
Polycythemia Vera
2
2016
12
0.250
 Why?
Animals
26
2025
35391
0.250
 Why?
Clinical Trials as Topic
4
2020
1005
0.250
 Why?
Hematopoietic Stem Cells
3
2022
382
0.250
 Why?
Cytogenetic Analysis
2
2022
32
0.240
 Why?
Mice
18
2025
16961
0.240
 Why?
Influenza Vaccines
1
2010
532
0.230
 Why?
Biomarkers, Tumor
4
2019
1164
0.230
 Why?
DEAD-box RNA Helicases
2
2015
66
0.230
 Why?
Transplantation, Haploidentical
1
2024
21
0.220
 Why?
Stem Cell Transplantation
3
2023
164
0.220
 Why?
Allografts
2
2021
137
0.220
 Why?
Influenza, Human
1
2010
601
0.220
 Why?
Azetidines
1
2024
40
0.220
 Why?
Antibodies, Monoclonal
4
2017
1366
0.210
 Why?
DNA Mutational Analysis
4
2019
382
0.210
 Why?
Finland
1
2023
90
0.210
 Why?
DNA-Binding Proteins
1
2010
1445
0.210
 Why?
RNA, Messenger
1
2010
2708
0.200
 Why?
Drug Therapy, Combination
4
2022
1042
0.200
 Why?
Disease Management
4
2021
588
0.200
 Why?
Antibodies, Neoplasm
3
2007
34
0.200
 Why?
Uncertainty
1
2023
121
0.200
 Why?
Interleukin-3 Receptor alpha Subunit
2
2019
17
0.200
 Why?
Proto-Oncogene Proteins c-myc
2
2022
131
0.190
 Why?
Lymphoma, Non-Hodgkin
1
2023
78
0.190
 Why?
Hematology
1
2022
15
0.190
 Why?
Thalidomide
2
2012
32
0.190
 Why?
Piperidines
1
2024
201
0.190
 Why?
Myeloproliferative Disorders
1
2022
26
0.190
 Why?
Amino Acid Transport System ASC
1
2022
12
0.190
 Why?
Succinate Dehydrogenase
2
2019
45
0.190
 Why?
Disease Progression
3
2023
2627
0.190
 Why?
Minor Histocompatibility Antigens
1
2022
46
0.190
 Why?
Receptors, Mitogen
1
2021
9
0.180
 Why?
Polymerase Chain Reaction
1
2024
1035
0.180
 Why?
Lectins, C-Type
1
2021
71
0.180
 Why?
Erythroblasts
1
2020
15
0.180
 Why?
Blood Cell Count
1
2020
53
0.180
 Why?
Cell Transformation, Neoplastic
3
2018
326
0.170
 Why?
Lipase
1
2020
66
0.170
 Why?
STAT3 Transcription Factor
1
2022
194
0.170
 Why?
Histocompatibility Testing
2
2019
120
0.170
 Why?
Inflammation Mediators
2
2020
505
0.170
 Why?
Tumor Lysis Syndrome
1
2019
8
0.160
 Why?
Dendritic Cells
1
2023
481
0.160
 Why?
Chemical and Drug Induced Liver Injury
1
2021
132
0.160
 Why?
Immunoconjugates
1
2021
104
0.160
 Why?
Leukopoiesis
1
2019
11
0.160
 Why?
Fatty Acids
2
2020
427
0.160
 Why?
NADPH Oxidase 2
1
2019
38
0.160
 Why?
Myeloid Progenitor Cells
1
2019
17
0.160
 Why?
Age Factors
5
2022
3152
0.160
 Why?
NF-kappa B p50 Subunit
1
2019
24
0.160
 Why?
Mycoses
1
2019
72
0.160
 Why?
K562 Cells
1
2019
85
0.160
 Why?
RAW 264.7 Cells
1
2019
49
0.150
 Why?
Genomics
3
2019
718
0.150
 Why?
Genetic Testing
2
2019
430
0.150
 Why?
Tricarboxylic Acids
1
2018
10
0.150
 Why?
Ketoglutaric Acids
1
2018
16
0.150
 Why?
Antibodies
1
2021
398
0.150
 Why?
United States
5
2023
13871
0.150
 Why?
Hematologic Diseases
1
2019
62
0.150
 Why?
Tumor Suppressor Protein p53
1
2022
507
0.150
 Why?
Antibiotic Prophylaxis
1
2019
101
0.150
 Why?
Cell Line, Tumor
7
2025
3186
0.150
 Why?
Amino Acids
2
2020
487
0.150
 Why?
Mitochondrial Proteins
2
2018
247
0.150
 Why?
Antimetabolites, Antineoplastic
1
2018
91
0.150
 Why?
Thiotepa
1
2018
20
0.150
 Why?
Calcium
1
2024
1212
0.150
 Why?
Lymphoma
2
2017
199
0.150
 Why?
Trees
1
2018
69
0.140
 Why?
Cysteine
1
2019
195
0.140
 Why?
Fusion Proteins, bcr-abl
2
2014
69
0.140
 Why?
Mediastinal Neoplasms
1
2017
38
0.140
 Why?
Confidence Intervals
1
2018
317
0.140
 Why?
HLA-DR Antigens
1
2018
223
0.140
 Why?
Hematinics
1
2017
20
0.130
 Why?
Infusions, Intravenous
1
2018
399
0.130
 Why?
AMP-Activated Protein Kinases
1
2018
191
0.130
 Why?
Hedgehog Proteins
1
2018
188
0.130
 Why?
Periodicals as Topic
1
2019
204
0.130
 Why?
Ataxia Telangiectasia Mutated Proteins
1
2016
66
0.130
 Why?
Cohort Studies
5
2022
5426
0.130
 Why?
Unrelated Donors
1
2016
36
0.130
 Why?
Genome, Human
1
2018
394
0.130
 Why?
Glucosephosphate Dehydrogenase
1
2016
56
0.130
 Why?
Energy Metabolism
2
2019
875
0.130
 Why?
Geriatric Assessment
1
2018
205
0.130
 Why?
Pyrimidines
2
2017
459
0.130
 Why?
Nitriles
1
2017
170
0.130
 Why?
NF-E2-Related Factor 2
1
2016
79
0.120
 Why?
Oncogene Proteins
1
2016
55
0.120
 Why?
Genetic Predisposition to Disease
2
2022
2274
0.120
 Why?
Mice, Inbred NOD
4
2019
587
0.120
 Why?
Receptor-Interacting Protein Serine-Threonine Kinases
1
2015
14
0.120
 Why?
Lipopolysaccharides
1
2019
877
0.120
 Why?
Electronic Health Records
1
2023
973
0.120
 Why?
Methyltransferases
1
2016
70
0.120
 Why?
Biomarkers
3
2022
3968
0.120
 Why?
Programmed Cell Death 1 Receptor
1
2017
232
0.120
 Why?
Myeloid-Lymphoid Leukemia Protein
1
2016
70
0.120
 Why?
Adolescent
7
2024
20412
0.120
 Why?
Hemoglobins
2
2018
339
0.120
 Why?
Oligomycins
1
2014
7
0.120
 Why?
Chromosome Aberrations
1
2015
147
0.120
 Why?
Mitochondrial Proton-Translocating ATPases
1
2014
17
0.120
 Why?
Homeostasis
1
2018
605
0.120
 Why?
Cell Survival
4
2022
1076
0.110
 Why?
In Situ Hybridization, Fluorescence
1
2015
313
0.110
 Why?
T-Lymphocytes
1
2022
1936
0.110
 Why?
Necrosis
1
2015
232
0.110
 Why?
Histone-Lysine N-Methyltransferase
1
2016
124
0.110
 Why?
Calcineurin Inhibitors
1
2014
68
0.110
 Why?
Cells, Cultured
5
2019
4084
0.110
 Why?
Vidarabine
2
2018
32
0.110
 Why?
Predictive Value of Tests
1
2019
1947
0.110
 Why?
Harringtonines
1
2013
2
0.110
 Why?
Tumor Suppressor Proteins
1
2016
314
0.110
 Why?
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
2013
1
0.110
 Why?
Alemtuzumab
3
2007
15
0.100
 Why?
Registries
2
2023
1899
0.100
 Why?
Gene Expression Profiling
3
2019
1687
0.100
 Why?
Glucose
1
2018
1002
0.100
 Why?
Phenotype
2
2019
3075
0.100
 Why?
Interleukin-1
1
2017
961
0.100
 Why?
Carbon Monoxide
1
2013
68
0.100
 Why?
Pyridazines
1
2013
54
0.100
 Why?
Gene Expression Regulation, Neoplastic
1
2018
1336
0.100
 Why?
Nausea
1
2012
111
0.100
 Why?
5-Methylcytosine
1
2012
21
0.100
 Why?
Liver
1
2020
1842
0.100
 Why?
Vomiting
1
2012
129
0.100
 Why?
Biopsy
1
2015
1088
0.090
 Why?
Imidazoles
1
2013
234
0.090
 Why?
Membrane Proteins
1
2018
1125
0.090
 Why?
Incidence
2
2016
2641
0.090
 Why?
Core Binding Factor Alpha 2 Subunit
2
2023
33
0.090
 Why?
Length of Stay
1
2016
1122
0.090
 Why?
Amino Acid Sequence
2
2015
2057
0.090
 Why?
Software
1
2015
608
0.090
 Why?
Fatigue
1
2012
318
0.090
 Why?
Dioxygenases
1
2010
28
0.090
 Why?
Sesquiterpenes
2
2016
53
0.090
 Why?
Oxidants
1
2011
109
0.090
 Why?
GTP-Binding Proteins
1
2011
158
0.080
 Why?
Chronic Disease
1
2016
1720
0.080
 Why?
Insulin Resistance
1
2018
1167
0.080
 Why?
Ethanol
1
2015
591
0.080
 Why?
Wasp Venoms
1
2009
4
0.080
 Why?
Protein Multimerization
1
2011
179
0.080
 Why?
Blast Crisis
2
2025
33
0.080
 Why?
Injections, Subcutaneous
1
2009
147
0.080
 Why?
Hydrogen Peroxide
1
2011
317
0.080
 Why?
Epinephrine
1
2009
141
0.080
 Why?
Mice, Transgenic
3
2023
2128
0.080
 Why?
Emergencies
1
2009
156
0.080
 Why?
Adjuvants, Immunologic
1
2010
221
0.080
 Why?
Immunization Schedule
1
2010
197
0.080
 Why?
RNA, Small Interfering
3
2016
591
0.070
 Why?
Inflammation
1
2019
2750
0.070
 Why?
Melphalan
1
2007
29
0.070
 Why?
Blood Transfusion
2
2020
295
0.070
 Why?
Transplantation Chimera
1
2007
54
0.070
 Why?
Tumor Cells, Cultured
2
2022
943
0.070
 Why?
Mice, Inbred C57BL
4
2020
5455
0.070
 Why?
Karnofsky Performance Status
1
2006
37
0.070
 Why?
HEK293 Cells
2
2019
698
0.070
 Why?
Receptors, Thrombopoietin
2
2016
5
0.060
 Why?
Calreticulin
2
2016
27
0.060
 Why?
Exome
2
2018
221
0.060
 Why?
Protein-Tyrosine Kinases
3
2014
431
0.060
 Why?
Janus Kinase 2
2
2016
32
0.060
 Why?
Ganciclovir
1
2006
52
0.060
 Why?
Evidence-Based Medicine
1
2010
712
0.060
 Why?
Valine
1
2006
81
0.060
 Why?
Acyclovir
1
2006
99
0.060
 Why?
Philadelphia Chromosome
2
2016
18
0.060
 Why?
Risk Factors
3
2014
9786
0.060
 Why?
Cell Proliferation
3
2020
2373
0.060
 Why?
Bone Marrow Transplantation
1
2006
277
0.060
 Why?
Pedigree
2
2015
487
0.060
 Why?
Janus Kinases
2
2015
12
0.060
 Why?
Oxidation-Reduction
2
2019
1028
0.060
 Why?
Cytomegalovirus Infections
1
2006
189
0.050
 Why?
Diamines
1
2023
3
0.050
 Why?
Antigens, CD34
1
2023
88
0.050
 Why?
Xenograft Model Antitumor Assays
2
2016
808
0.050
 Why?
Breast Neoplasms
1
2015
2133
0.050
 Why?
Chemotaxis
1
2023
129
0.050
 Why?
Flow Cytometry
2
2018
1159
0.050
 Why?
Angiogenesis Inhibitors
1
2004
219
0.050
 Why?
Practice Guidelines as Topic
1
2010
1501
0.050
 Why?
Neutropenia
1
2022
137
0.050
 Why?
Drug Interactions
2
2013
395
0.050
 Why?
Early Termination of Clinical Trials
1
2021
15
0.050
 Why?
Quinuclidines
1
2020
9
0.040
 Why?
Clinical Trials, Phase II as Topic
1
2020
72
0.040
 Why?
Hyperbilirubinemia
1
2020
11
0.040
 Why?
Receptors, Cell Surface
1
2022
381
0.040
 Why?
Antiviral Agents
1
2006
715
0.040
 Why?
Niacinamide
1
2020
75
0.040
 Why?
Proportional Hazards Models
2
2017
1198
0.040
 Why?
Neoplasms, Second Primary
1
2021
106
0.040
 Why?
Lentivirus
1
2019
53
0.040
 Why?
Multicenter Studies as Topic
1
2020
286
0.040
 Why?
Disease Susceptibility
1
2021
334
0.040
 Why?
Daunorubicin
1
2018
26
0.040
 Why?
Consolidation Chemotherapy
1
2018
9
0.040
 Why?
Mice, Nude
2
2015
682
0.040
 Why?
Maintenance Chemotherapy
1
2018
22
0.040
 Why?
Iron
1
2020
282
0.040
 Why?
Drug Monitoring
1
2020
215
0.040
 Why?
Mice, Knockout
2
2016
2881
0.040
 Why?
Myeloablative Agonists
1
2018
21
0.040
 Why?
Mice, SCID
1
2019
350
0.040
 Why?
Datasets as Topic
1
2018
109
0.040
 Why?
Cause of Death
1
2020
395
0.040
 Why?
Forkhead Transcription Factors
1
2019
183
0.040
 Why?
Clinical Decision-Making
1
2021
301
0.040
 Why?
Whole-Body Irradiation
1
2018
76
0.040
 Why?
Fetal Blood
1
2020
317
0.040
 Why?
Antineoplastic Agents, Immunological
1
2020
181
0.040
 Why?
HLA Antigens
1
2019
234
0.040
 Why?
Child
2
2024
20884
0.040
 Why?
Disease Models, Animal
2
2020
4078
0.040
 Why?
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor
1
2017
15
0.040
 Why?
Cell Count
1
2018
312
0.040
 Why?
Biological Transport
1
2018
404
0.030
 Why?
Glutathione
1
2019
348
0.030
 Why?
Tumor Stem Cell Assay
1
2017
32
0.030
 Why?
Combined Modality Therapy
1
2020
1203
0.030
 Why?
Retinal Dehydrogenase
1
2017
30
0.030
 Why?
Diet, High-Fat
1
2018
239
0.030
 Why?
Oxides
1
2017
41
0.030
 Why?
Arsenicals
1
2017
32
0.030
 Why?
Glycolysis
1
2018
315
0.030
 Why?
Benzothiazoles
1
2016
32
0.030
 Why?
Adenosine Triphosphate
1
2019
479
0.030
 Why?
NADP
1
2016
47
0.030
 Why?
Heterografts
1
2017
133
0.030
 Why?
Hydrazines
1
2016
34
0.030
 Why?
Tumor Microenvironment
1
2020
627
0.030
 Why?
Cyclophosphamide
1
2017
234
0.030
 Why?
Deoxyglucose
1
2016
52
0.030
 Why?
Myeloid Ecotropic Viral Integration Site 1 Protein
1
2016
10
0.030
 Why?
Drug Combinations
1
2017
331
0.030
 Why?
Reactive Oxygen Species
1
2019
593
0.030
 Why?
Transcriptome
1
2022
876
0.030
 Why?
Sequence Analysis, RNA
1
2018
427
0.030
 Why?
Sample Size
1
2016
116
0.030
 Why?
Receptors, Interleukin-1
1
2017
218
0.030
 Why?
Kinetics
1
2019
1645
0.030
 Why?
p38 Mitogen-Activated Protein Kinases
1
2017
276
0.030
 Why?
Health Services Accessibility
1
2023
903
0.030
 Why?
Positron-Emission Tomography
1
2017
282
0.030
 Why?
Isoenzymes
1
2016
301
0.030
 Why?
Splenomegaly
1
2015
16
0.030
 Why?
Metabolome
1
2018
340
0.030
 Why?
Lipid Metabolism
1
2018
503
0.030
 Why?
Repressor Proteins
1
2018
406
0.030
 Why?
Phosphatidylinositol 3-Kinases
1
2017
361
0.030
 Why?
Intercellular Signaling Peptides and Proteins
1
2017
374
0.030
 Why?
Comorbidity
2
2013
1547
0.030
 Why?
Dihydrolipoyllysine-Residue Acetyltransferase
1
2014
6
0.030
 Why?
Ketone Oxidoreductases
1
2014
7
0.030
 Why?
Hydroxyurea
1
2015
34
0.030
 Why?
Diagnosis, Differential
1
2019
1432
0.030
 Why?
Fluorescent Antibody Technique
1
2015
376
0.030
 Why?
Interleukin-1beta
1
2017
372
0.030
 Why?
Imatinib Mesylate
1
2014
75
0.030
 Why?
Quality of Life
2
2016
2688
0.030
 Why?
Membrane Potential, Mitochondrial
1
2014
67
0.030
 Why?
Cell Differentiation
1
2022
1891
0.030
 Why?
Immunologic Factors
1
2017
230
0.030
 Why?
Sirolimus
1
2016
270
0.030
 Why?
Sequence Homology, Amino Acid
1
2015
372
0.030
 Why?
Superoxides
1
2014
201
0.030
 Why?
Dasatinib
1
2014
54
0.030
 Why?
Age of Onset
1
2015
495
0.030
 Why?
Structure-Activity Relationship
1
2015
545
0.030
 Why?
Thiazoles
1
2014
117
0.030
 Why?
Research Design
1
2020
1045
0.030
 Why?
Genetic Heterogeneity
1
2014
58
0.030
 Why?
Leukemia, Lymphoid
1
2013
27
0.030
 Why?
Drug Synergism
1
2014
370
0.030
 Why?
Up-Regulation
1
2016
840
0.030
 Why?
Trans-Activators
1
2016
393
0.030
 Why?
Cyclosporine
1
2014
263
0.030
 Why?
Pulmonary Diffusing Capacity
1
2013
74
0.030
 Why?
RNA Interference
1
2014
450
0.030
 Why?
Phosphorylation
1
2017
1713
0.020
 Why?
Polymorphism, Single Nucleotide
1
2020
2060
0.020
 Why?
Mice, Inbred BALB C
1
2015
1250
0.020
 Why?
Homeodomain Proteins
1
2016
494
0.020
 Why?
Cost-Benefit Analysis
1
2015
569
0.020
 Why?
Thrombosis
1
2015
348
0.020
 Why?
Leupeptins
1
2011
9
0.020
 Why?
HL-60 Cells
1
2011
34
0.020
 Why?
Respiratory Function Tests
1
2013
581
0.020
 Why?
Proteasome Inhibitors
1
2011
42
0.020
 Why?
Cysteine Proteinase Inhibitors
1
2011
50
0.020
 Why?
Mitoxantrone
1
2010
14
0.020
 Why?
Free Radical Scavengers
1
2011
82
0.020
 Why?
Genotype
1
2015
1833
0.020
 Why?
Molecular Sequence Data
1
2015
2835
0.020
 Why?
Etoposide
1
2010
148
0.020
 Why?
Prospective Studies
2
2016
7135
0.020
 Why?
Proteasome Endopeptidase Complex
1
2011
149
0.020
 Why?
Neoplasms, Experimental
1
2011
170
0.020
 Why?
Acetylcysteine
1
2011
146
0.020
 Why?
Prevalence
1
2016
2564
0.020
 Why?
Mutagenesis, Site-Directed
1
2011
361
0.020
 Why?
Models, Biological
1
2017
1724
0.020
 Why?
Treatment Failure
1
2010
339
0.020
 Why?
Insulin
1
2018
2326
0.020
 Why?
RNA-Binding Proteins
1
2011
387
0.020
 Why?
Nitroimidazoles
1
2004
9
0.010
 Why?
Cyclohexanes
1
2004
21
0.010
 Why?
Fluorescein
1
2004
24
0.010
 Why?
In Situ Nick-End Labeling
1
2004
123
0.010
 Why?
Radiation-Sensitizing Agents
1
2004
39
0.010
 Why?
Lectins
1
2004
48
0.010
 Why?
Microcirculation
1
2004
145
0.010
 Why?
In Situ Hybridization
1
2004
297
0.010
 Why?
Neoplasm Transplantation
1
2004
256
0.010
 Why?
Capillaries
1
2004
103
0.010
 Why?
Antibiotics, Antineoplastic
1
2004
123
0.010
 Why?
Angiography
1
2004
196
0.010
 Why?
Wilms Tumor
1
2004
78
0.010
 Why?
Neovascularization, Pathologic
1
2004
296
0.010
 Why?
Vascular Endothelial Growth Factor A
1
2004
530
0.010
 Why?
Immunohistochemistry
1
2004
1685
0.010
 Why?
Hypoxia
1
2004
1084
0.010
 Why?
Pollyea's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (466) concept(s)
_
Co-Authors Expand Description
See all (57) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)